Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer

Uterine endometrial cancer is one of the most common gynecological malignancies worldwide. With relatively few options for late-line therapies for advanced or relapsed endometrial cancer, the use of pretreated therapies may broaden the choice of treatments. Here, we report a case of recurrent micros...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Kaito Mimura, Akihiko Shimomura, Tomoko Gota, Kenju Ando, Yukino Kawamura, Tomoko Taniyama, Hajime Oishi, Chikako Shimizu
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2022-12-01
Ráidu:	Gynecologic Oncology Reports
Fáttát:	Immune checkpoint inhibitor Tyrosine kinase inhibitor Immunotherapy Tumor microenvironment Combination therapy
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S2352578922001643
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!